An overview of some potential immunotherapeutic options against COVID-19
M Bayat, Y Asemani, MR Mohammadi, M Sanaei… - International …, 2021 - Elsevier
After the advent of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV2)
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
in the late 2019, the resulting severe and pernicious syndrome (COVID-19) immediately was …
Promising Immunotherapies against COVID‐19
H Guo, L Zhou, Z Ma, Z Tian, F Zhou - Advanced Therapeutics, 2021 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2), has led to a severe pandemic and deeply affected …
syndrome coronavirus 2 (SARS‐CoV‐2), has led to a severe pandemic and deeply affected …
Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19
The pandemic coronavirus disease 2019 (COVID-19) is instigated by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) that is mainly transmitted via the …
respiratory syndrome coronavirus 2 (SARS-CoV-2) that is mainly transmitted via the …
Advances in immunotherapy for COVID-19: A comprehensive review
M Masoomikarimi, B Garmabi, J Alizadeh… - International …, 2021 - Elsevier
COVID-19 is an acute respiratory syndrome caused by SARS-COV-2 which has now
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
become a huge pandemic worldwide. The immunopathogenesis of COVID-19 has been …
Passive Immunotherapeutic Approaches for Treating Covid-19: A Comprehensive Review
R Aadhith, PB Devi - … Journal of Pharmaceutical Research and Allied …, 2022 - ijpras.com
During the recent pandemic, COVID-19 (SARS-CoV-2) was the causative agent of the
severe acute respiratory syndrome, which resulted in thousands of cases and high mortality …
severe acute respiratory syndrome, which resulted in thousands of cases and high mortality …
[HTML][HTML] Immune-based therapeutic approaches in COVID-19
Abstract Coronavirus disease 2019 (COVID-19) is a viral disease caused by severe acute
respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the Coronaviridae family …
respiratory syndrome coronavirus-2 (SARS-CoV-2), a member of the Coronaviridae family …
Immune-based therapy for COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel zoonotic virus
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …
identified as the cause of coronavirus disease 2019 (COVID-19) that has crossed species …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar - International Immunopharmacology, 2020 - Elsevier
Emerging infectious diseases always pose a threat to humans along with plant and animal
life. SARS-CoV2 is the recently emerged viral infection that originated from Wuhan city of the …
life. SARS-CoV2 is the recently emerged viral infection that originated from Wuhan city of the …
Potential therapeutic options for COVID-19: an update on current evidence
Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …
pandemic and is a major public health concern nowadays. The rapid and global spread of …